Skip to main content

Centessa Pharmaceuticals plc

CNTADelisted Jun 24, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001847903

Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.

Q3 2021 vs. Q2 2021

How the institutions holding Centessa Pharmaceuticals plc changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of CNTA: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders5040−10
Shares47.4M56.9M+9.51M (+20.0%)
Value$1.05B$947.5M−$97.9M (−9.4%)

New holders (6)

Institutions that held Centessa Pharmaceuticals plc at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to CNTA in Q3 2021
InstitutionSharesValue% of portfolio
D. E. Shaw & Co., Inc.12,420$207.0K0.00%
Morgan Stanley7,630$128.0K0.00%
Compagnie Lombard Odier SCmA2,750$46.0K0.00%
Royal Bank of Canada453$8.00K0.00%
Evolution Wealth Advisors, LLC160$3.00K0.00%
State of Wyoming23$00.00%

Sold out (16)

Institutions that held Centessa Pharmaceuticals plc at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of CNTA in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Wellington Management Group LLP1,106,577$24.6M
Avoro Capital Advisors LLC500,000$11.1M
Monashee Investment Management LLC130,000$2.89M
State of Wisconsin Investment Board80,381$1.78M
BVF Inc58,900$1.31M
Tudor Investment Corp Et Al43,079$957.0K
Temasek Holdings (Private) Ltd41,680$926.0K
Blackstone Group Inc.40,000$888.0K
Squarepoint Ops LLC37,771$839.0K
Marshall Wace North America L.P.34,228$760.0K
Northern Trust Corp18,400$409.0K
Two Sigma Investments, LP9,973$222.0K
Geode Capital Management, LLC9,513$211.0K
BlackRock Inc.4,992$110.0K
Pinz Capital Management, LP900$20.0K
US Bancorp19$0